# Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Proposed Modification of Dispensing Restrictions for Buprenorphine and Buprenorphine Combination as Used in Approved Opioid Treatment Medications; Correction
> **US Department of Health and Human Services** · Final rule; correction. · Published 2015-06-18 · Effective 2015-06-18 · 80 FR 34837
## Document
- **Document number:** 2015-14421
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 80 FR 34837
- **CFR reference:** 42 CFR 8
- **Publication date:** 2015-06-18
- **Effective date:** 2015-06-18
- **HHS docket:** Docket No. 2012-29417
## Abstract

The Health and Human Services Department (HHS) is correcting a final rule that appeared in the Federal Register of December 6, 2012. The document modified the dispensing requirements buprenorphine and buprenorphine combination products approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. In particular, this rule allows opioid treatment programs more flexibility in dispensing take-home supplies of buprenorphine after the assessment and documentation of a patient's responsibility and stability to receive opioid addiction treatment medication. However, an inadvertent removal of paragraphs was made. This correction reinstates the missing paragraphs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2015/06/18/2015-14421/opioid-drugs-in-maintenance-and-detoxification-treatment-of-opiate-addiction-proposed-modification)
---
*AI Analytics · CC0 1.0*